tiprankstipranks
Trending News
More News >
HBM Holdings Ltd. (HK:2142)
:2142
Hong Kong Market

HBM Holdings Ltd. (2142) Similar Stocks

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
HBM Holdings Ltd.
HK$7.79
HK$6.51B
268.62
518.25%
Alphamab Oncology
HK$6.79
HK$6.69B
36.19
163.18%
Lepu Biopharma Co. Ltd. Class H
HK$5.82
HK$9.10B
43.70%
Abbisko Cayman Limited
HK$10.38
HK$6.80B
176.83
232.69%
0 Buy
0 Hold
0 Sell
Moderate Buy
CStone Pharmaceuticals
HK$4.10
HK$5.29B
276.15%
Shandong Boan Biotechnology Company., Limited. Class H
HK$12.44
HK$7.14B
80.52
35.36%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2142
HBM Holdings Ltd.
7.79
6.49
499.23%
HK:9966
Alphamab Oncology
6.79
4.38
181.74%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.82
1.87
47.34%
HK:2256
Abbisko Cayman Limited
10.38
7.16
222.36%
HK:2616
CStone Pharmaceuticals
4.10
3.03
283.18%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
12.44
3.16
34.05%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis